Anat Hakim
SVP, GC & Secretary, Eli Lilly and Company.
Companies
- Eli Lilly and CompanySVP, GC & Secretary Mar 3, 2021 to now1
- Eli Lilly and CompanyGeneral counsel Feb 7, 2020 to Mar 3, 20202
- WellCareGeneral counsel Sep 29, 2016 to Jan 27, 20203
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY38,687 shares4$49.2M at $1,272.75Aug 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 7, 2026Sold 5,000 shares at $1,190.00 of Eli Lilly and Company4
- Feb 9, 2026Granted 8,278 shares at $1,044.67 of Eli Lilly and Company5
- Feb 1, 2026Shares withheld for tax 2,953 shares at $1,037.15 of Eli Lilly and Company6
- Feb 1, 2026Exercised options 6,700 shares of Eli Lilly and Company6
- May 2, 2025Gift 17,875 shares of Eli Lilly and Company7
- Feb 10, 2025Granted 10,321 shares at $868.88 of Eli Lilly and Company8
- Feb 1, 2025Shares withheld for tax 2,166 shares at $811.08 of Eli Lilly and Company9
- Feb 1, 2025Exercised options 4,904 shares of Eli Lilly and Company9
- Aug 12, 2024Gift 14,700 shares of Eli Lilly and Company10
- Feb 12, 2024Granted 5,815 shares at $737.26 of Eli Lilly and Company11
- Feb 1, 2024Shares withheld for tax 1,967 shares at $645.61 of Eli Lilly and Company12
- Feb 1, 2024Exercised options 4,442 shares of Eli Lilly and Company12
- Feb 10, 2023Granted 9,072 shares at $345.12 of Eli Lilly and Company13
- Feb 1, 2023Shares withheld for tax 3,393 shares at $344.15 of Eli Lilly and Company14
- Feb 1, 2023Exercised options 7,646 shares of Eli Lilly and Company14
- Mar 1, 2022Shares withheld for tax 3,500 shares at $249.95 of Eli Lilly and Company15
- Mar 1, 2022Exercised options 7,929 shares of Eli Lilly and Company15
- Mar 1, 2021Shares withheld for tax 3,493 shares at $204.89 of Eli Lilly and Company16
- Mar 1, 2021Exercised options 7,928 shares of Eli Lilly and Company16
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | LLY | Sale | $6.0M | +5.6% | −5.7% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARWellCare, General counsel
- 4
- 5SEC EDGARForm 4 filed Feb 11, 2026
- 6SEC EDGARForm 4 filed Feb 3, 2026
- 7SEC EDGARForm 4 filed May 5, 2025
- 8SEC EDGARForm 4 filed Feb 12, 2025
- 9SEC EDGARForm 4 filed Feb 4, 2025
- 10SEC EDGARForm 4 filed Aug 13, 2024
- 11SEC EDGARForm 4 filed Feb 14, 2024
- 12SEC EDGARForm 4 filed Feb 2, 2024
- 13SEC EDGARForm 4 filed Feb 14, 2023
- 14SEC EDGARForm 4 filed Feb 3, 2023
- 15SEC EDGARForm 4 filed Mar 3, 2022
- 16SEC EDGARForm 4 filed Mar 3, 2021